These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 9143857)

  • 21. Zotepine in levodopa-induced Psychosis.
    Spieker S; Stetter F; Klockgether T
    Mov Disord; 1995 Nov; 10(6):795-7. PubMed ID: 8750001
    [No Abstract]   [Full Text] [Related]  

  • 22. The management of the levodopa psychoses.
    Friedman JH
    Clin Neuropharmacol; 1991 Aug; 14(4):283-95. PubMed ID: 1680556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parkinson's disease: making the diagnosis, selecting drug therapies.
    Scharre DW; Mahler ME
    Geriatrics; 1994 Oct; 49(10):14-6, 20-3. PubMed ID: 7926845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quetiapine improves psychotic symptoms and cognition in Parkinson's disease.
    Juncos JL; Roberts VJ; Evatt ML; Jewart RD; Wood CD; Potter LS; Jou HC; Yeung PP
    Mov Disord; 2004 Jan; 19(1):29-35. PubMed ID: 14743357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs.
    Ikeguchi K; Kuroda A
    Eur Arch Psychiatry Clin Neurosci; 1995; 244(6):320-4. PubMed ID: 7772616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hallucinations in Parkinson's disease].
    Moser A; Hagenah J; Kömpf D
    Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Three patients with Parkinson's disease whose therapeutic levels were successfully improved after administration of quetiapine for suppression of psychosis].
    Kodama R; Morita S; Miwa H; Kondo T
    No To Shinkei; 2003 May; 55(5):413-7. PubMed ID: 12833883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dopaminomimetic psychosis in Parkinson's disease: first symptom of early dementia?].
    Catalan-Alonso MJ; Del Val J
    Rev Neurol; 2001 Jun 1-15; 32(11):1085-7. PubMed ID: 11562835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Usefulness of olanzapine in the levodopa-induced psychosis in patients with Parkinson's disease].
    Chacón JR; Durán E; Durán JA; Alvarez M
    Neurologia; 2002 Jan; 17(1):7-11. PubMed ID: 11834192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ziprasidone in Parkinson's disease psychosis.
    Connemann BJ; Schönfeldt-Lecuona C
    Can J Psychiatry; 2004 Jan; 49(1):73. PubMed ID: 14763682
    [No Abstract]   [Full Text] [Related]  

  • 32. Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug-induced psychosis.
    Arnold G; Trenkwalder C; Schwarz J; Oertel WH
    Mov Disord; 1994 Mar; 9(2):238-40. PubMed ID: 7910949
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacotherapy for Parkinson's disease.
    Chen JJ; Swope DM
    Pharmacotherapy; 2007 Dec; 27(12 Pt 2):161S-173S. PubMed ID: 18041936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ziprasidone in Parkinsonian dopamine psychosis].
    Durán-Ferreras E; Alvarez-López M; García-Moreno JM; Chacón J
    Rev Neurol; 2008 Apr 16-30; 46(8):476-80. PubMed ID: 18428105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine.
    Normann C; Hesslinger B; Frauenknecht S; Berger M; Walden J
    Pharmacopsychiatry; 1997 Nov; 30(6):263-5. PubMed ID: 9442549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkinson's disease: drug-induced psychiatric states.
    Factor SA; Molho ES; Podskalny GD; Brown D
    Adv Neurol; 1995; 65():115-38. PubMed ID: 7872135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Idiopathic Parkinson's disease: practical hints for the treatment].
    Ludin HP
    Praxis (Bern 1994); 2005 Jul; 94(30-31):1147-50. PubMed ID: 16117469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of psychosis in Parkinson's disease: safety considerations.
    Fernandez HH; Trieschmann ME; Friedman JH
    Drug Saf; 2003; 26(9):643-59. PubMed ID: 12814332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease.
    Parkinson Study Group
    N Engl J Med; 1999 Mar; 340(10):757-63. PubMed ID: 10072410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Othello syndrome in patients with Parkinson's disease.
    Georgiev D; Danieli A; Ocepek L; Novak D; Zupancic-Kriznar N; Trost M; Pirtosek Z
    Psychiatr Danub; 2010 Mar; 22(1):94-8. PubMed ID: 20305599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.